Home Health Care Paves the Way for Respiratory Devices Innovations

A growing number of patients today are suffering from respiratory diseases such as COPD or asthma, along with respiratory problems caused by injuries, surgery, or trauma. The overall reduction in blood oxygen levels that can occur due to respiratory illnesses can be severely detrimental to the patient’s health. Respiratory devices are therefore of great help for these patients as they allow for a better supply of oxygen to the body. The more common type of respiratory devices involve directly pumping oxygen rich air into the patient’s lungs, while other devices involve the monitoring of a patient’s carbon dioxide levels. Another type includes the removal of water or moisture from within a patient’s lung, thereby allowing an easier breathing.

The global respiratory devices market is expected to expand at a CAGR of 6.1% within a forecast period from 2017 to 2025. The market is likely to reach US$22.1 bn by the end of this forecast period.

Would Home Care Continue as a Primary Motivator for Players?

One of the primary factors augmenting the demand for respiratory devices at the moment is the growing demand for them in home healthcare fields. Home healthcare is currently one of the more significant aspects in the overall healthcare industry, largely driven by the growing number of geriatric patients, accident and trauma victims, and patients suffering from chronic illnesses, diabetes, and obesity. The stress on the healthcare industry is increasing by the day while number of beds each place can hold is only limited. As a result, innovations and developments have been moving towards caring for and monitoring patients at their own homes, and the global respiratory devices market is a huge part of this.

How are Players Reacting to the Changes in Market Scenario?

The competitive landscape of the global respiratory devices market is also being shaped by the growing demand for home health care services. The highly fragmented market is showing stronger signs of leading players taking up consolidation efforts, especially in emerging economies, through the introduction of home health care respiratory devices.

The global respiratory devices market is also being guided strongly by the current innovations in the use of these devices in more than simply support roles. For instance, Vectura recently partnered up with Dynavax to devise more clinical applications of its technologies, especially in the use of lung cancer treatment. Dynavax will be using Akita, a smart nebulizer by Vectura, on lung cancer patients, to induce immune system response through the introduction of a type of protein.

Meanwhile, assisted breathing will likely remain a heavy demand generating factor for the global respiratory devices market over the coming years, while innovations continue to remodel the market’s trajectory.


Post a Comment

Note: only a member of this blog may post a comment.

Latest Post

Market Research Reports